Profil
Alif Saleh is currently Chief Executive Officer & Director at 28bio, Inc. since 2024.
Formerly, Mr. Saleh was Chief Executive Officer & Director at Scipher Medicine Corp.
from 2016 to 2024 and Senior Business Director at PTTGC Innovation America Corp.
from 2008 to 2012.
Education includes graduation from the Faculty of Engineering, Lund University.
Aktive Positionen von Alif Saleh
| Unternehmen | Position | Beginn |
|---|---|---|
AxoSim, Inc.
AxoSim, Inc. Packaged SoftwareTechnology Services Develops engineered human brain and peripheral nerve organoid models by integrating tissue engineering, neural interfacing and AI | Vorstandsvorsitzender | 11.06.2024 |
Ehemalige bekannte Positionen von Alif Saleh
| Unternehmen | Position | Ende |
|---|---|---|
Scipher Medicine Corp.
Scipher Medicine Corp. Miscellaneous Commercial ServicesCommercial Services Provides RNA data analysis for the treatment of autoimmune diseases and develops AI platform | Vorstandsvorsitzender | 09.05.2024 |
PTTGC Innovation America Corp.
PTTGC Innovation America Corp. Chemicals: AgriculturalProcess Industries Manufactures agricultural chemicals | Corporate Officer/Principal | 01.09.2012 |
Ausbildung von Alif Saleh
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
PTTGC Innovation America Corp.
PTTGC Innovation America Corp. Chemicals: AgriculturalProcess Industries Manufactures agricultural chemicals | Process Industries |
Faculty of Engineering, Lund University
Faculty of Engineering, Lund University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scipher Medicine Corp.
Scipher Medicine Corp. Miscellaneous Commercial ServicesCommercial Services Provides RNA data analysis for the treatment of autoimmune diseases and develops AI platform | Commercial Services |
AxoSim, Inc.
AxoSim, Inc. Packaged SoftwareTechnology Services Develops engineered human brain and peripheral nerve organoid models by integrating tissue engineering, neural interfacing and AI | Technology Services |
















